Bio Banking Stem cell
The collection and storage of human tissue samples has been available for centuries in medicine, Biobanking of stem cells involves the collection, processing, and long-term storage of stem cells in cryogenic conditions for future medical use. Stem cells, which have the ability to differentiate into various cell types, are invaluable in regenerative medicine, disease modeling, and personalized therapies. Biobanks preserve stem cells derived from sources like bone marrow, umbilical cord blood, or induced pluripotent stem cells (iPSCs), ensuring their viability for future clinical applications or research. This resource can potentially provide treatments for various conditions, including blood disorders, degenerative diseases, and cancer, as well as enable advancements in gene therapy and tissue engineering. however, , biobanking has recently become a dedicated profession. Advances in technology that have allowed the fragmentation storage, and long-term functioning of ex vivo human cells, as well as the acquisition of relevant scientific knowledge, including genetic information, have opened up considerable opportunities to improve biomedical research. At the same time, these potential issues raise complex ethical issues regarding tissue donors, researchers using samples and public awareness of biobanking as a whole. This article aims to review the performance of stem cell biobanks, related ethical issues and the legal framework in Spain.Special consideration will be given to the new but flexible appearance of pluripotent stem cells. Many of the topics discussed here will be in the framework of stem cells acquired by adult bankers, which do not include in themselves any significant behavioral problem.
Related Conference of Bio Banking Stem cell
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Bio Banking Stem cell Conference Speakers
Recommended Sessions
- Bio Banking Stem cell
- Bone Marrow Transplantation
- CAR-T Cell Therapy: Current Status and Future Directions
- Cell and Genetic Therapy
- Cellular Reprogramming and Induced Pluripotent Stem Cells
- Clinical Methods
- Dental Stem Cells
- ell-Based Therapies for Neurological Disorders
- Neurodegenerative Disease
- Research and Development of Stem Cell & Regenerative Drugs
- Stem Cell Animal Applications
- Stem Cell Apoptosis and Signal Transmission
- Stem Cell Embryology
- Stem Cell in Drug Discovery
- Theories of Aging in Stem Biology
- Tissue Engineering
- Tissue Engineering and 3d Cell Culture
- Translational Research in Stem Cell Assessments
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)
